Last reviewed · How we verify
Haemophilus Influenza type b vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Haemophilus Influenza type b vaccine (Haemophilus Influenza type b vaccine) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Haemophilus Influenza type b vaccine TARGET | Haemophilus Influenza type b vaccine | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Haemophilus Influenza type b vaccine CI watch — RSS
- Haemophilus Influenza type b vaccine CI watch — Atom
- Haemophilus Influenza type b vaccine CI watch — JSON
- Haemophilus Influenza type b vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Haemophilus Influenza type b vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/haemophilus-influenza-type-b-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab